Healthcare Services Group, Inc. (HCSG) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q4 26	$0.22	$0.32	+45.5%	—	—	—
Q3 26	$0.22	$0.37	+68.2%	—	—	—
Q2 26	$0.22	$0.44	+100.0%	—	—	—
Q1 26	$0.2	$0.59	+195.0%	—	—	—
Q4 25	$0.2	-$0.44	-320.0%	—	—	—
Q3 25	$0.19	$0.23	+21.1%	—	—	—
Q2 25	$0.2	$0.16	-20.0%	—	—	—
Q1 25	$0.2	$0.19	-5.0%	—	—	—
Q4 24	$0.2	$0.2	0.0%	—	—	—
Q3 24	$0.19	$0.22	+15.8%	—	—	—
Q2 24	$0.16	$0.2	+25.0%	—	—	—
Q1 24	$0.17	$0.16	-5.9%	—	—	—
Q4 23	$0.17	$0.12	-29.4%	—	—	—
Q3 23	$0.13	$0.17	+30.8%	—	—	—
Q2 23	$0.11	$0.22	+100.0%	—	—	—
Q1 23	$0.13	$0.09	-30.8%	—	—	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$0.82	—	—	$1.8B	—
FY24	—	$0.54	—	—	$1.7B	—
FY23	—	$0.52	—	—	$1.7B	—
FY22	—	$0.47	—	—	$1.7B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$1.6B	$1.9B	$2B	$1.8B	$1.8B	$1.6B	$1.7B	$1.7B	$1.7B	$1.8B
YoY change	+8.76%	+19.1%	+7.6%	-8.08%	-4.37%	-6.72%	+2.94%	-1.11%	+2.65%	+7.08%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	1.6B	1.9B	2B	1.8B	1.8B	1.6B	1.7B	1.7B	1.7B	1.8B
Cost of revenue	1.3B	1.6B	1.8B	1.6B	1.5B	1.4B	1.5B	1.5B	1.5B	1.6B
Gross profit	223.2M	250.6M	234.4M	227.9M	268M	230.6M	193.3M	214.7M	228.1M	239.4M
Gross margin	14.3%	13.5%	11.7%	12.4%	15.2%	14%	11.4%	12.8%	13.3%	13%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	103.9M	126.7M	136.6M	150M	141.6M	166.4M	149.5M	160.1M	174.8M	183.6M
Operating expenses	103.9M	126.7M	136.6M	150M	141.6M	166.4M	149.5M	160.1M	174.8M	183.6M
Operating income	119.2M	123.9M	97.8M	77.9M	126.4M	64.1M	43.8M	54.7M	53.3M	55.8M
Operating margin	7.63%	6.66%	4.89%	4.23%	7.18%	3.91%	2.59%	3.27%	3.1%	3.04%
Non-operating income, net	1.1M	10.4M	5.2M	10.7M	4.2M	2.8M	3.8M	6.3M	6.1M	13.6M
Pretax income	120.4M	133M	99.9M	85.1M	129.2M	65.5M	44.6M	53.1M	52.9M	67.9M
Income tax	43M	44.7M	16.4M	20.5M	30.5M	17M	10.3M	14.7M	13.5M	8.8M
Net income	77.4M	88.2M	83.5M	64.6M	98.7M	48.5M	34.2M	38.4M	39.5M	59.1M
Net margin	4.95%	4.74%	4.17%	3.51%	5.61%	2.96%	2.03%	2.3%	2.3%	3.21%
EBITDA	125.6M	132.8M	107.1M	91.8M	140.7M	78.8M	59.1M	69M	67.9M	72.6M
EPS	1.06	1.2	1.13	0.87	1.32	0.61	0.47	0.52	0.54	0.82
Diluted EPS	1.05	1.19	1.12	0.87	1.32	0.61	0.47	0.52	0.53	0.81

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	411.4M	423.8M	423.4M	426.3M	428.1M	437.8M	447.7M	458.5M	464.3M	466.7M	462.8M	470.8M
Cost of revenue	376.9M	350.4M	358.9M	384.7M	364.7M	379.2M	379.7M	455.5M	367.9M	394.6M	386.9M	396M
Gross profit	34.5M	73.5M	64.5M	41.5M	63.4M	58.6M	68M	3M	96.4M	72.1M	75.8M	74.8M
Gross margin	8.37%	17.3%	15.2%	9.75%	14.8%	13.4%	15.2%	0.65%	20.8%	15.4%	16.4%	15.9%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	40.3M	42.2M	42.8M	43.2M	44.5M	44.4M	46.4M	44.5M	46.8M	45.8M	43.6M	45.7M
Operating expenses	40.3M	42.2M	42.8M	43.2M	44.5M	44.4M	46.4M	44.5M	46.8M	45.8M	43.6M	45.7M
Operating income	-5.8M	31.3M	21.7M	-1.6M	18.9M	14.3M	21.5M	-41.6M	49.6M	26.2M	32.3M	29.1M
Operating margin	-1.42%	7.38%	5.13%	-0.38%	4.43%	3.26%	4.81%	-9.06%	10.7%	5.62%	6.97%	6.18%
Non-operating income, net	1.6M	1.8M	1.6M	1.4M	1.4M	1.7M	2.8M	86K	8.1M	2.7M	2.6M	2.5M
Pretax income	-6.3M	31M	21.3M	-2M	18.8M	14.8M	23.9M	-41.9M	57.3M	28.6M	34.5M	31M
Income tax	-1.3M	8.4M	6M	-198K	4.8M	2.9M	6.7M	-9.5M	14.4M	-2.7M	8.5M	8.3M
Net income	-5M	22.6M	15.3M	-1.8M	14M	11.9M	17.2M	-32.4M	43M	31.2M	26.1M	22.7M
Net margin	-1.23%	5.33%	3.62%	-0.42%	3.28%	2.72%	3.85%	-7.06%	9.25%	6.69%	5.63%	4.82%
EBITDA	-2.6M	35M	25.3M	2M	22.7M	17.9M	25.4M	-36.6M	53.6M	30.1M	36.1M	32.6M
EPS	-0.07	0.31	0.21	-0.02	0.19	0.16	0.23	-0.44	0.59	0.44	0.37	0.33
Diluted EPS	-0.07	0.31	0.21	-0.02	0.19	0.16	0.23	-0.44	0.59	0.44	0.37	0.32

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	2.8B	3.9B	3B	1.8B	2.1B	1.3B	892M	770.4M	857M	1.4B	1.4B
Enterprise value	2.8B	3.8B	2.9B	1.7B	1.8B	1.2B	803.6M	659.1M	757.7M	1.2B	1.3B
Shares outstanding	72.8M	73.4M	74M	74.4M	74.7M	74.8M	74.3M	74.3M	73.8M	72.4M	72.4M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	36.8	43.8	35.6	28	21.3	27.4	26.1	20.1	21.7	23.4	12.1
P/S	1.82	2.08	1.48	0.98	1.19	0.81	0.53	0.46	0.5	0.75	0.76
P/B	8.41	9.67	6.75	3.93	4.37	2.94	2.13	1.69	1.71	2.71	2.72
EV/EBITDA	22	28.8	27.1	18.6	13.1	14.7	13.6	9.55	11.2	16.9	9.57
EV/Sales	1.77	2.05	1.45	0.93	1.05	0.7	0.48	0.39	0.44	0.67	0.7
Earnings yield	2.72%	2.28%	2.81%	3.57%	4.7%	3.65%	3.84%	4.98%	4.61%	4.27%	8.24%
FCF yield	1.26%	0.06%	2.53%	4.93%	10.1%	2.36%	-1.5%	4.94%	2.85%	10.1%	4.93%
PEG	—	—	—	—	—	—	—	—	—	—	-0.07

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	14.3%	13.5%	11.7%	12.4%	15.2%	14%	11.4%	12.8%	13.3%	13%	15.9%
Operating margin	7.63%	6.66%	4.89%	4.23%	7.18%	3.91%	2.59%	3.27%	3.1%	3.04%	4.72%
Net margin	4.95%	4.74%	4.17%	3.51%	5.61%	2.96%	2.03%	2.3%	2.3%	3.21%	6.59%
ROE	22.8%	22.1%	18.9%	14%	20.5%	10.7%	8.19%	8.41%	7.9%	11.6%	24.7%
ROA	14.6%	13.1%	12.1%	8.94%	12.6%	6.24%	4.75%	4.85%	4.92%	7.44%	9.84%
ROIC	31%	23.3%	22.2%	16.2%	42.4%	17%	10.2%	11.4%	9.91%	13.8%	30%
Return on tangible assets	18.8%	17.2%	15.5%	11.2%	15.3%	8.28%	6.37%	6.24%	6.24%	9.51%	19.7%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	4.11	2.86	3.11	3.47	3.53	2.86	2.69	2.64	2.89	3.38	3.02
Quick ratio	3.74	2.63	2.86	3.22	3.33	2.72	2.58	2.55	2.8	3.28	2.94
Debt / equity	—	0.09	0.07	0.05	0.02	0.02	0.08	0.08	0.02	0.02	0.03
Debt / assets	—	0.05	0.04	0.03	0.01	0.01	0.05	0.05	0.01	0.01	0.02
Net debt / EBITDA	—	-0.36	-0.68	-1.05	-1.8	-2.21	-1.5	-1.61	-1.46	-2.18	-0.96
Interest coverage	—	98.6	33.3	25.6	95	48.3	15.9	7.75	9.22	44	87.5
Effective tax rate	35.7%	33.6%	16.4%	24.1%	23.6%	25.9%	23.1%	27.7%	25.4%	13%	18.8%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	21.5	25.4	27.1	24.8	23.6	21.9	22.7	22.5	23.3	25.4	26.5
EPS (basic)	1.06	1.2	1.13	0.87	1.32	0.61	0.47	0.52	0.54	0.82	0.82
EPS (diluted)	1.05	1.19	1.12	0.87	1.32	0.61	0.47	0.52	0.53	0.81	1.71
Book value per share	4.66	5.45	5.96	6.19	6.43	6.05	5.63	6.15	6.78	7.05	7.63
FCF per share	0.49	0.03	1.01	1.2	2.85	0.42	-0.18	0.51	0.33	1.92	2.12
Cash per share	1.26	1.13	1.38	1.59	3.54	2.48	1.63	1.98	1.45	2.32	2.4
Capex per share	0.07	0.07	0.06	0.06	0.05	0.07	0.06	0.07	0.08	—	—

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	0.33%	0.27%	0.21%	0.23%	0.23%	0.33%	0.28%	0.32%	0.36%	—	—
Capex / operating cash flow	26.1%	-200.2%	18.4%	7.13%	2.54%	9.06%	-12.6%	-513.1%	-425.6%	—	—
Payout ratio	68.9%	62.6%	68.5%	91.3%	61.5%	128.2%	185.1%	0%	0%	—	0%
Dividend yield	1.87%	1.43%	1.92%	3.26%	2.89%	4.68%	7.1%	0%	0%	—	4.14%

Yield

4.14%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.215

ex-dividend Nov 17, 2022

Payout ratio

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Nov 17, 2022	$0.215
Aug 18, 2022	$0.2137
May 19, 2022	$0.2125
Feb 24, 2022	$0.2112
Nov 18, 2021	$0.21
Aug 19, 2021	$0.2087
May 20, 2021	$0.2075

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$411.4M	$423.8M	$423.4M	$426.3M	$428.1M	$437.8M	$447.7M	$458.5M	$464.3M	$466.7M	$462.8M	$470.8M
YoY change	-0.75%	-0.04%	+1.49%	+1.76%	+4.07%	+3.3%	+5.72%	+7.55%	+8.45%	+6.59%	+3.37%	+2.69%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	91.6M	82.8M	102.4M	118M	264.3M	185.2M	121.5M	147.5M	107.3M	168M
Receivables	271.3M	378.7M	341.8M	340.9M	255.5M	293.4M	336.8M	383.5M	330.9M	281.3M
Inventory	37.8M	42.4M	41.4M	36.5M	31.6M	26M	21.2M	18.5M	16.7M	16.8M
Total current assets	414.6M	527.4M	508.1M	515.7M	572.4M	546.4M	508.6M	571.7M	556.7M	576.4M
Property, plant & equipment	13.5M	13.5M	12.9M	28.8M	26.6M	28.1M	23M	28.8M	28.2M	27.6M
Goodwill & intangibles	117.7M	163.9M	155.2M	146.9M	138.5M	191.1M	182.9M	175.3M	169.9M	173.5M
Total assets	528.4M	676M	692.6M	722.6M	785M	777.5M	720.8M	790.7M	802.8M	794.3M
Accounts payable	42.9M	74.5M	61.5M	54.4M	52.2M	64.4M	68.3M	83.2M	81.1M	77.4M
Short-term debt	—	35.4M	30M	10M	—	—	25M	25M	—	—
Total current liabilities	100.9M	184.2M	163.4M	148.7M	162.3M	191.1M	189M	216.9M	192.5M	170.4M
Long-term debt	—	—	0	11.6M	11.4M	11.3M	8.1M	11.2M	8M	9.7M
Total liabilities	189.6M	276.1M	251.8M	262.3M	304.6M	324.9M	302.6M	334M	302.8M	284M
Shareholders' equity	338.8M	400M	440.8M	460.3M	480.5M	452.7M	418.3M	456.6M	499.9M	510.2M
Total debt	—	35.4M	30M	21.6M	11.4M	11.3M	33.1M	36.2M	8M	9.7M
Net debt	—	25.8M	4M	-5.7M	-128M	-59.5M	6.8M	-18.1M	-48.7M	-115.5M

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	121.3M	147.5M	104.9M	105.6M	103.8M	107.3M	114.8M	134.5M	177.5M	168M	178.6M	164.7M
Receivables	367.8M	383.5M	407.1M	398.9M	406.5M	330.9M	337.9M	292.2M	288.5M	281.3M	299.4M	292.8M
Inventory	19.2M	18.5M	18M	17.9M	17M	16.7M	17.3M	17.4M	17.2M	16.8M	15.9M	15.8M
Total current assets	533.4M	571.7M	580.4M	573.2M	578.1M	556.7M	575M	532.3M	580.6M	576.4M	601.2M	568.5M
Property, plant & equipment	29.1M	28.8M	29.2M	29.8M	28.4M	28.2M	29.3M	28.2M	26.9M	27.6M	27M	29.9M
Goodwill & intangibles	176.7M	175.3M	174M	172.6M	171.3M	169.9M	180.1M	176.6M	175.3M	173.5M	172.2M	197.8M
Total assets	750.7M	790.7M	803.9M	799.7M	805.8M	802.8M	823M	802.2M	804.3M	794.3M	814.8M	820.9M
Accounts payable	70.6M	83.2M	72.9M	72.2M	76.6M	81.1M	78.8M	77.9M	81.7M	77.4M	83.1M	86.1M
Short-term debt	45M	25M	40M	30M	25M	—	—	8.3M	7.6M	—	5.3M	6.4M
Total current liabilities	187.8M	216.9M	209.4M	209.5M	197.2M	192.5M	198.7M	213.9M	195.6M	170.4M	193.4M	188.1M
Long-term debt	11.6M	11.2M	10.6M	10.7M	9M	8M	7.9M	7M	6.2M	9.7M	9.4M	11.3M
Total liabilities	309M	334M	329.3M	328.3M	317.1M	302.8M	308.8M	325.2M	308.3M	284M	301.1M	302M
Shareholders' equity	441.7M	456.6M	474.6M	471.4M	488.7M	499.9M	514.2M	477M	496M	510.2M	513.8M	518.8M
Total debt	56.6M	36.2M	50.6M	40.7M	34M	8M	7.9M	15.4M	13.9M	9.7M	14.7M	17.7M
Net debt	25.3M	-18.1M	21.3M	14.2M	7M	-48.7M	-56.4M	-67.5M	-110.5M	-115.5M	-121.5M	-105.7M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	77.4M	88.2M	83.5M	64.6M	98.7M	48.5M	34.2M	38.4M	39.5M	59.1M
Depreciation & amortization	7.5M	8.9M	9.3M	13.9M	14.3M	14.7M	15.3M	14.3M	14.6M	16.8M
Stock-based compensation	4.3M	6M	5.9M	6.9M	7.9M	8.8M	9.2M	9M	9.2M	12M
Change in working capital	-69.4M	-107.5M	-62.3M	-26.3M	45.3M	-15.7M	-99.6M	-56.8M	-61.2M	13.1M
Operating cash flow	19.8M	-2.5M	23.4M	58.4M	160.2M	60.4M	-38.3M	-1M	-1.4M	145M
Capital expenditure	-5.2M	-5.1M	-4.3M	-4.2M	-4.1M	-5.5M	-4.8M	-5.3M	-6.1M	—
Investing cash flow	-6.5M	-15M	-9.6M	-16.5M	-36.8M	-23M	2.6M	-3.3M	6M	-5.3M
Dividends paid	-53.3M	-55.2M	-57.2M	-59M	-60.7M	-62.2M	-63.4M	0	0	—
Share repurchases	—	—	—	0	0	-21.5M	0	-11.3M	-5M	-61.6M
Financing cash flow	-50.3M	-19.8M	-62.8M	-79.4M	-71.3M	-85.1M	-39.3M	-12.2M	-31M	-63.3M
Net change in cash	-36.9M	-37.3M	-49M	-37.5M	52.1M	-47.6M	-75.1M	-16.5M	-26.4M	76.3M
Free cash flow	36M	2.2M	75.1M	89.2M	212.9M	31.4M	-13.4M	38.1M	24.5M	139.2M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	-5M	22.6M	15.3M	-1.8M	14M	11.9M	17.2M	-32.4M	43M	31.2M	26.1M	22.7M
Depreciation & amortization	3.3M	3.8M	3.6M	3.7M	3.8M	3.6M	3.9M	5M	4M	3.9M	3.8M	3.5M
Stock-based compensation	2.4M	2.2M	2.5M	2.1M	2.2M	2.3M	3.7M	2.5M	2.6M	3.1M	2.8M	2.8M
Change in working capital	4M	6.5M	-34.7M	-19.5M	-1.6M	-2.1M	7.9M	-12.5M	-539K	17.9M	-3.3M	-12.7M
Operating cash flow	346K	34.4M	-13.5M	-19.1M	20.3M	14.4M	31.2M	-51.1M	71.3M	17.4M	43.7M	21.9M
Capital expenditure	-1.8M	-1.4M	-2.2M	-1.2M	-1.4M	-1.4M	-1.7M	-1.3M	—	—	—	—
Investing cash flow	-1.3M	-1.4M	11.7M	-27.8M	288K	21.8M	-14.5M	-2.4M	-1.4M	9.9M	-10.2M	-12.2M
Dividends paid	0	0	—	—	—	—	—	—	—	—	—	—
Share repurchases	-4M	-5M	0	-3M	-1M	-1M	-7M	-7.7M	-27.3M	-19.6M	-24M	-20.9M
Financing cash flow	984K	-25M	14M	-13M	-6M	-26M	-8.8M	-7.7M	-27.3M	-19.6M	-28.1M	-20.9M
Net change in cash	57K	8M	12.2M	-59.8M	14.5M	10.2M	8M	-61.1M	42.6M	7.7M	5.4M	-11.3M
Free cash flow	1.1M	48M	-28.2M	15M	2.9M	34.8M	25.8M	27.4M	70M	16M	42.3M	20.2M

Date	Ratio
Nov 15, 2010	3:2
Aug 13, 2007	3:2
May 3, 2005	3:2
Mar 2, 2004	3:2
Aug 28, 1998	3:2
Nov 18, 1991	3:2
Apr 10, 1985	3:2
Oct 29, 1984	3:2

Healthcare Services Group, Inc. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement

Split history